The 81st Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 3-11C ATL: Prognostic Factors

Sun. Oct 13, 2019 2:30 PM - 3:30 PM No.11 (Tokyo International Forum, 5F G502)

Chair: Kenji Ishitsuka (Department of Hematology and Rheumatology, Kagoshima University Hospital)

Carmina Louise H. Guerrero1, Yoshiko Yamashita2, Megumi Kuba-Miyara3, Naoki Imaizumi4, Shugo Sakihama5, Masaki Hayashi6, Takashi Miyagi7, Satoko Morishima8, Kennosuke Karube5, Hiroaki Masuzaki8, Takuya Fukushima1 (1.Laboratory of Hematoimmunology, Graduate School of Health Sciences, University of the Ryukyus, Nishihara City, Okinawa, Japan, 2.HealthTech Business Development Office, Corporate Business Development Division, NEC Corporation, Minato, Tokyo, Japan, 3.Okinawa University, Naha, Okinawa, Japan, 4.Laboratory of Molecular Genetics, Graduate School of Health Sciences, University of the Ryukyus, Nishihara, Okinawa, Japan, 5.Department of Pathology and Cell Biology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan, 6.Department of Hematology, Nakagami Hospital, Okinawa, Okinawa, Japan, 7.Department of Hematology, Heart Life Hospital, Nakagusuku, Okinawa, Japan, 8.Division of Endocrinology, Diabetes and Metabolism, Hematology, Rheumatology (Second Department of Internal Medicine), Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan)

Kosuke Toyoda1, Kunihiro Tsukasaki2, Ryunosuke Machida3, Tomohiro Kadota3, Takuya Fukushima4, Kenji Ishitsuka5, Dai Maruyama6, Hirokazu Nagai7 (1.Hematol., Rheumatol. and Infectious Diseases, Kumamoto Univ., Kumamoto, Japan, 2.Hematol., International Medical Center, Saitama Medical Univ., Saitama, Japan, 3.JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan, 4.Lab. of Hematoimmunology, Univ. of the Ryukyus, Okinawa, Japan, 5.Hematol. and Immunol., Kagoshima Univ. Hospital, Kagoshima, Japan, 6.Hematol., National Cancer Center Hospital, Tokyo, Japan, 7.Hematol., National Hospital Organization Nagoya Medical Center, Nagoya, Japan)

Ayumu Kubota1, Nobuaki Nakano1, Masahito Tokunaga1, Takayoshi Miyazono1, Jun Odawara1, Tomohisa Tabuchi1, Mayumi Tokunaga1, Torahiko Makino1, Shogo Takeuchi1, Kentaro Yonekura2, Yukie Tashiro3, Yoshifusa Takatsuka1, Yoshikiyo Ito1, Atae Utsunomiya1 (1.Department of Hematology, Imamura General Hospital, Kagoshima, Japan, 2.Department of Dermatology, Imamura General Hospital, Kagoshima, Japan, 3.Department of Pathology, Imamura General Hospital, Kagoshima, Japan)

Kazuho Morichika1, Riko Miyagi1, Sakiko Kitamura1, Sachie Uchibori1, Shohei Tomori1, Taeko Hanashiro1, Natsuki Shimabukuro1, Keita Tamaki1, Iori Tedokon1, Yukiko Nishi1, Sawako Nakachi1, Takashi Miyagi2, Kazuiku Ohshiro3, Satoko Morishima1, Takuya Fukushima4, Kennosuke Karube5, Hiroaki Masuzaki1 (1.Second Department of Internal Medicine, Ryukyu University, Okinawa, Japan, 2.Department of Hematology, Heartlife Hospital, Japan, 3.Department of Hematology, Okinawa Prefectural Nanbu Medical Center, Japan, 4.Laboratory of Hematoimmunology, School of Health Sciences, Ryukyu University, Japan, 5.Department of Pathology and Cell Biology, Ryukyu University, Japan)